Apollo Hospitals & Abbott join forces to build India’s first cardiac registry
Apollo Hospitals becomes the first to adopt Abbott's High Sensitive Troponin-I blood test technology to screen otherwise healthy people for the risk of developing heart disease. The collaboration will focus on generating India-specific insights to enable physicians and patients to better manage cardiac outcomes